1. Home
  2. CLX vs UTHR Comparison

CLX vs UTHR Comparison

Compare CLX & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clorox Company (The)

CLX

Clorox Company (The)

HOLD

Current Price

$105.06

Market Cap

13.2B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$488.92

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLX
UTHR
Founded
1913
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
20.3B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
CLX
UTHR
Price
$105.06
$488.92
Analyst Decision
Hold
Buy
Analyst Count
12
12
Target Price
$135.42
$495.08
AVG Volume (30 Days)
2.2M
424.3K
Earning Date
11-03-2025
10-29-2025
Dividend Yield
4.73%
N/A
EPS Growth
121.91
16.08
EPS
6.38
26.38
Revenue
$6,771,000,000.00
$3,128,400,000.00
Revenue This Year
N/A
$13.64
Revenue Next Year
$4.85
$5.78
P/E Ratio
$16.44
$18.55
Revenue Growth
N/A
13.50
52 Week Low
$98.20
$266.98
52 Week High
$171.37
$492.62

Technical Indicators

Market Signals
Indicator
CLX
UTHR
Relative Strength Index (RSI) 41.74 68.10
Support Level $105.00 $470.13
Resistance Level $108.18 $492.62
Average True Range (ATR) 2.37 10.72
MACD 0.69 -0.53
Stochastic Oscillator 66.73 89.55

Price Performance

Historical Comparison
CLX
UTHR

About CLX Clorox Company (The)

Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: